(VIANEWS) - Franchise Group (FRG), MGP Ingredients (MGPI), The Carlyle Group (CG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Franchise Group (FRG)
59.3% sales growth and 6.1% return on equity
Franchise Group, Inc. operates as a retailer, franchisor operator, and acquirer of franchised and franchisable businesses.
Franchise Group's sales growth this year is expected to be 43.3% and 8.6% for next year.
Year-on-year quarterly revenue growth grew by 73.4%, now sitting on 2.64B for the twelve trailing months.
Volume
Today's last reported volume for Franchise Group is 162803 which is 20.38% below its average volume of 204482.
Franchise Group's sales growth for the next quarter is 59.3%. The company's growth estimates for the ongoing quarter and the next is 433.3% and 88.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.1%.
Volatility
Franchise Group's last day, last week, and last month's current intraday variation average was 0.84%, 1.74%, and 2.25%, respectively.
Franchise Group's highest amplitude of average volatility was 2.81% (day), 2.59% (last week), and 3.36% (last month), respectively.
Franchise Group's Stock Yearly Top and Bottom Value
Franchise Group's stock is valued at $45.46 at 15:22 EST, way below its 52-week high of $52.17 and way higher than its 52-week low of $25.28.
Franchise Group's Moving Average
Franchise Group's value is way above its 50-day moving average of $40.09 and way above its 200-day moving average of $37.01.Previous days news about Franchise Group(FRG)
- According to Benzinga on Thursday, 2 December, "ARCpoint Franchise Group LLC, formed under the laws of the state of South Carolina in February 2005, is the franchisor of ARCpoint Labs and supports over 125 independently owned locations. "
2. MGP Ingredients (MGPI)
45.4% sales growth and 16.33% return on equity
MGP Ingredients, Inc., together with its subsidiaries, produces and supplies distilled spirits, and specialty wheat proteins and starch food ingredients.
MGP Ingredients's sales growth this year is expected to be 45.9% and 11.3% for next year.
Year-on-year quarterly revenue growth grew by 71.5%, now sitting on 560.79M for the twelve trailing months.
Volume
Today's last reported volume for MGP Ingredients is 106702 which is 6.19% above its average volume of 100476.
MGP Ingredients's sales growth is a negative 0% for the ongoing quarter and 45.4% for the next. The company's growth estimates for the present quarter and the next is a negative 34.4% and negative -46.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.33%.
Volatility
MGP Ingredients's last day, last week, and last month's current intraday variation average was 0.53%, 0.98%, and 2.40%, respectively.
MGP Ingredients's highest amplitude of average volatility was 3.70% (day), 2.75% (last week), and 4.78% (last month), respectively.
MGP Ingredients's Stock Yearly Top and Bottom Value
MGP Ingredients's stock is valued at $76.00 at 15:22 EST, under its 52-week high of $79.52 and way above its 52-week low of $42.43.
MGP Ingredients's Moving Average
MGP Ingredients's worth is way above its 50-day moving average of $68.48 and way higher than its 200-day moving average of $65.70.3. The Carlyle Group (CG)
37.5% sales growth and 80.56% return on equity
The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments.
The Carlyle Group's sales growth this year is expected to be 43.8% and 11.2% for next year.
Year-on-year quarterly revenue growth grew by 139.3%, now sitting on 7.69B for the twelve trailing months.
Volume
Today's last reported volume for The Carlyle Group is 2411090 which is 11.35% above its average volume of 2165310.
The Carlyle Group's sales growth is a negative 0% for the present quarter and 37.5% for the next. The company's growth estimates for the present quarter and the next is 105% and 45.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 80.56%.
Volatility
The Carlyle Group's last day, last week, and last month's current intraday variation average was 3.84%, 3.23%, and 2.03%, respectively.
The Carlyle Group's highest amplitude of average volatility was 6.11% (day), 4.63% (last week), and 2.82% (last month), respectively.
The Carlyle Group's Stock Yearly Top and Bottom Value
The Carlyle Group's stock is valued at $53.17 at 15:22 EST, way under its 52-week high of $60.62 and way above its 52-week low of $28.12.
The Carlyle Group's Moving Average
The Carlyle Group's worth is under its 50-day moving average of $53.43 and way higher than its 200-day moving average of $45.68.Previous days news about The Carlyle Group(CG)
- According to MarketWatch on Wednesday, 1 December, "Arnold, a 14-year member of the Disney board, previously was an operating executive at equity investment firm The Carlyle Group from 2013 to 2021. "
- According to MarketWatch on Wednesday, 1 December, "Arnold, a 14-year member of the Disney board, previously was an operating executive at equity investment firm The Carlyle Group from 2013 to 2021. "
4. AtriCure (ATRC)
22.5% sales growth and 10.02% return on equity
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally.
AtriCure's sales growth this year is anticipated to be 32.5% and 17.6% for next year.
Year-on-year quarterly revenue growth grew by 28.7%, now sitting on 258.84M for the twelve trailing months.
Volume
Today's last reported volume for AtriCure is 227659 which is 11.26% above its average volume of 204613.
AtriCure's sales growth for the next quarter is 22.5%. The company's growth estimates for the current quarter and the next is a negative 3.6% and 28.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.02%.
Volatility
AtriCure's last day, last week, and last month's current intraday variation average was 3.68%, 5.35%, and 3.15%, respectively.
AtriCure's highest amplitude of average volatility was 5.01% (day), 8.99% (last week), and 5.39% (last month), respectively.
AtriCure's Stock Yearly Top and Bottom Value
AtriCure's stock is valued at $67.94 at 15:22 EST, way below its 52-week high of $89.18 and way higher than its 52-week low of $43.67.
AtriCure's Moving Average
AtriCure's value is under its 50-day moving average of $73.95 and under its 200-day moving average of $73.12.5. Equity Bancshares (EQBK)
14.2% sales growth and 13.29% return on equity
Equity Bancshares, Inc. operates as the bank holding company for Equity Bank that provides a range of banking, mortgage banking, and financial services to individual and corporate customers.
Equity Bancshares's sales growth this year is expected to be 9.3% and 5.6% for next year.
Year-on-year quarterly revenue growth grew by 21.1%, now sitting on 175.7M for the twelve trailing months.
Volume
Today's last reported volume for Equity Bancshares is 33121 which is 28.86% below its average volume of 46562.
Equity Bancshares's sales growth for the next quarter is 14.2%. The company's growth estimates for the current quarter and the next is a negative 20.5% and negative -37.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.29%.
Volatility
Equity Bancshares's last day, last week, and last month's current intraday variation average was 1.70%, 1.03%, and 1.14%, respectively.
Equity Bancshares's highest amplitude of average volatility was 2.77% (day), 2.08% (last week), and 2.43% (last month), respectively.
Equity Bancshares's Stock Yearly Top and Bottom Value
Equity Bancshares's stock is valued at $33.11 at 15:22 EST, under its 52-week high of $36.00 and way higher than its 52-week low of $19.91.
Equity Bancshares's Moving Average
Equity Bancshares's value is under its 50-day moving average of $33.92 and above its 200-day moving average of $30.92.6. Vishay Intertechnology (VSH)
9.7% sales growth and 18.36% return on equity
Vishay Intertechnology, Inc. manufactures and supplies discrete semiconductors and passive electronic components in Asia, Europe, and the Americas.
Vishay Intertechnology's sales growth this year is anticipated to be 28.8% and 1.6% for next year.
Year-on-year quarterly revenue growth grew by 27.1%, now sitting on 3.06B for the twelve trailing months.
Volume
Today's last reported volume for Vishay Intertechnology is 808523 which is 3.13% below its average volume of 834681.
Vishay Intertechnology's sales growth for the next quarter is 9.7%. The company's growth estimates for the present quarter and the next is 117.9% and 21.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.36%.
Volatility
Vishay Intertechnology's last day, last week, and last month's current intraday variation average was 0.59%, 1.94%, and 1.24%, respectively.
Vishay Intertechnology's highest amplitude of average volatility was 3.57% (day), 3.34% (last week), and 2.73% (last month), respectively.
Vishay Intertechnology's Stock Yearly Top and Bottom Value
Vishay Intertechnology's stock is valued at $20.49 at 15:22 EST, way below its 52-week high of $26.50 and above its 52-week low of $19.00.
Vishay Intertechnology's Moving Average
Vishay Intertechnology's worth is higher than its 50-day moving average of $20.31 and below its 200-day moving average of $22.45.7. Rush Enterprises (RUSHA)
6.1% sales growth and 16.2% return on equity
Rush Enterprises, Inc., through its subsidiaries, operates as an integrated retailer of commercial vehicles and related services in the United States.
Rush Enterprises's sales growth this year is expected to be 6.2% and 11.8% for next year.
Year-on-year quarterly revenue growth grew by 7.5%, now sitting on 5.08B for the twelve trailing months.
Volume
Today's last reported volume for Rush Enterprises is 95952 which is 49.29% below its average volume of 189223.
Rush Enterprises's sales growth for the next quarter is 6.1%. The company's growth estimates for the present quarter and the next is 31.9% and 24.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.2%.
Volatility
Rush Enterprises's last day, last week, and last month's current intraday variation average was 0.34%, 0.90%, and 1.47%, respectively.
Rush Enterprises's highest amplitude of average volatility was 2.35% (day), 2.45% (last week), and 3.40% (last month), respectively.
Rush Enterprises's Stock Yearly Top and Bottom Value
Rush Enterprises's stock is valued at $55.64 at 15:22 EST, under its 52-week high of $57.66 and way higher than its 52-week low of $37.68.
Rush Enterprises's Moving Average
Rush Enterprises's value is way higher than its 50-day moving average of $49.90 and way above its 200-day moving average of $47.12.8. Ameren (AEE)
5.9% sales growth and 10.4% return on equity
Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States.
Ameren's sales growth this year is anticipated to be 6.1% and 4.4% for next year.
Year-on-year quarterly revenue growth grew by 5.5%, now sitting on 5.74B for the twelve trailing months.
Volume
Today's last reported volume for Ameren is 3207560 which is 227% above its average volume of 980900.
Ameren's sales growth for the next quarter is 5.9%. The company's growth estimates for the current quarter and the next is 8.8% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.4%.
Volatility
Ameren's last day, last week, and last month's current intraday variation average was 2.16%, 1.51%, and 1.35%, respectively.
Ameren's highest amplitude of average volatility was 2.59% (day), 2.41% (last week), and 1.97% (last month), respectively.
Ameren's Stock Yearly Top and Bottom Value
Ameren's stock is valued at $81.59 at 15:22 EST, way below its 52-week high of $90.77 and way higher than its 52-week low of $69.79.